Dean Michael Cestari, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Optic Neuropathy, Ischemic | 11 | 2024 | 87 | 2.840 |
Why?
|
| Optic Nerve Diseases | 11 | 2020 | 342 | 2.710 |
Why?
|
| Oculomotor Muscles | 7 | 2023 | 405 | 2.200 |
Why?
|
| Optic Neuritis | 8 | 2019 | 175 | 2.080 |
Why?
|
| Optic Disk | 10 | 2018 | 422 | 1.980 |
Why?
|
| Eye Diseases | 6 | 2019 | 658 | 1.780 |
Why?
|
| Optic Atrophy, Hereditary, Leber | 5 | 2021 | 50 | 1.390 |
Why?
|
| Esotropia | 3 | 2019 | 99 | 1.350 |
Why?
|
| Optic Disk Drusen | 2 | 2021 | 38 | 1.310 |
Why?
|
| Vision Disorders | 11 | 2020 | 1093 | 1.120 |
Why?
|
| Ophthalmologic Surgical Procedures | 3 | 2019 | 354 | 1.090 |
Why?
|
| Fluorescein Angiography | 9 | 2021 | 1086 | 1.080 |
Why?
|
| Optic Nerve | 7 | 2022 | 571 | 1.050 |
Why?
|
| Tomography, Optical Coherence | 11 | 2021 | 2957 | 0.950 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 3 | 2018 | 251 | 0.900 |
Why?
|
| Graves Ophthalmopathy | 4 | 2018 | 135 | 0.890 |
Why?
|
| Retinal Ganglion Cells | 5 | 2017 | 811 | 0.860 |
Why?
|
| Intracranial Hypertension | 3 | 2021 | 193 | 0.840 |
Why?
|
| Giant Cell Arteritis | 4 | 2017 | 307 | 0.830 |
Why?
|
| Abducens Nerve Diseases | 2 | 2015 | 44 | 0.800 |
Why?
|
| Strabismus | 2 | 2018 | 320 | 0.770 |
Why?
|
| Ophthalmology | 4 | 2020 | 560 | 0.750 |
Why?
|
| Nystagmus, Pathologic | 2 | 2014 | 104 | 0.750 |
Why?
|
| Neuromyelitis Optica | 3 | 2019 | 266 | 0.740 |
Why?
|
| Macula Lutea | 2 | 2021 | 180 | 0.710 |
Why?
|
| Optic Nerve Neoplasms | 1 | 2020 | 45 | 0.710 |
Why?
|
| Visual Fields | 8 | 2018 | 1067 | 0.700 |
Why?
|
| Nervous System Diseases | 3 | 2018 | 1665 | 0.680 |
Why?
|
| Neurofibromatosis 1 | 2 | 2019 | 561 | 0.670 |
Why?
|
| Eye Infections | 1 | 2019 | 62 | 0.650 |
Why?
|
| Cranial Nerve Diseases | 1 | 2020 | 111 | 0.650 |
Why?
|
| Neurocutaneous Syndromes | 1 | 2019 | 53 | 0.640 |
Why?
|
| Scotoma | 3 | 2017 | 128 | 0.640 |
Why?
|
| Vascular Neoplasms | 1 | 2020 | 167 | 0.620 |
Why?
|
| Mitochondrial Diseases | 2 | 2016 | 344 | 0.620 |
Why?
|
| DNA, Mitochondrial | 4 | 2021 | 872 | 0.610 |
Why?
|
| Vision, Low | 3 | 2009 | 162 | 0.600 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2019 | 108 | 0.600 |
Why?
|
| Eye Neoplasms | 1 | 2019 | 306 | 0.580 |
Why?
|
| Arteritis | 2 | 2016 | 158 | 0.580 |
Why?
|
| Vision, Binocular | 1 | 2019 | 225 | 0.570 |
Why?
|
| Retinal Vessels | 3 | 2018 | 864 | 0.570 |
Why?
|
| Meningioma | 2 | 2020 | 1226 | 0.570 |
Why?
|
| Diplopia | 2 | 2023 | 217 | 0.570 |
Why?
|
| Pseudotumor Cerebri | 1 | 2018 | 107 | 0.560 |
Why?
|
| Visual Acuity | 8 | 2020 | 2714 | 0.530 |
Why?
|
| Optic Nerve Injuries | 1 | 2017 | 150 | 0.530 |
Why?
|
| Eye | 2 | 2023 | 712 | 0.520 |
Why?
|
| Autoantigens | 2 | 2018 | 891 | 0.510 |
Why?
|
| Eye Movements | 1 | 2019 | 514 | 0.510 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2019 | 2171 | 0.510 |
Why?
|
| Blindness | 3 | 2016 | 587 | 0.510 |
Why?
|
| Orbital Neoplasms | 1 | 2017 | 223 | 0.500 |
Why?
|
| Visual Field Tests | 7 | 2020 | 415 | 0.500 |
Why?
|
| Central Nervous System Diseases | 1 | 2020 | 521 | 0.490 |
Why?
|
| Hemangioma, Cavernous | 1 | 2015 | 107 | 0.480 |
Why?
|
| Temporal Arteries | 3 | 2011 | 155 | 0.480 |
Why?
|
| Injections, Intraocular | 1 | 2014 | 36 | 0.470 |
Why?
|
| Huntington Disease | 1 | 2021 | 1147 | 0.470 |
Why?
|
| Tacrolimus | 1 | 2018 | 750 | 0.460 |
Why?
|
| Horner Syndrome | 1 | 2014 | 35 | 0.460 |
Why?
|
| Sarcoidosis | 1 | 2020 | 535 | 0.450 |
Why?
|
| GTP Phosphohydrolases | 2 | 2017 | 524 | 0.450 |
Why?
|
| Retinal Artery Occlusion | 2 | 2016 | 83 | 0.450 |
Why?
|
| Autonomic Nerve Block | 1 | 2014 | 82 | 0.450 |
Why?
|
| Optic Atrophy, Autosomal Dominant | 1 | 2013 | 8 | 0.450 |
Why?
|
| Leiomyosarcoma | 1 | 2017 | 425 | 0.440 |
Why?
|
| Cataract Extraction | 1 | 2017 | 465 | 0.430 |
Why?
|
| Autoimmune Diseases | 2 | 2018 | 2258 | 0.420 |
Why?
|
| Sensory Deprivation | 1 | 2013 | 109 | 0.420 |
Why?
|
| Nerve Regeneration | 2 | 2022 | 799 | 0.420 |
Why?
|
| Fundus Oculi | 4 | 2020 | 560 | 0.420 |
Why?
|
| Tuberous Sclerosis | 1 | 2019 | 1042 | 0.380 |
Why?
|
| Evoked Potentials, Visual | 3 | 2021 | 420 | 0.380 |
Why?
|
| Axons | 3 | 2022 | 1678 | 0.370 |
Why?
|
| Retina | 3 | 2020 | 2661 | 0.370 |
Why?
|
| Amblyopia | 1 | 2013 | 152 | 0.370 |
Why?
|
| Interferon-alpha | 1 | 2015 | 910 | 0.370 |
Why?
|
| Retinal Vasculitis | 1 | 2011 | 46 | 0.370 |
Why?
|
| Point Mutation | 1 | 2016 | 1596 | 0.350 |
Why?
|
| Hypotension | 1 | 2016 | 888 | 0.350 |
Why?
|
| Whipple Disease | 1 | 2010 | 20 | 0.340 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2020 | 1437 | 0.340 |
Why?
|
| Glucocorticoids | 4 | 2018 | 2167 | 0.340 |
Why?
|
| Humans | 83 | 2024 | 768970 | 0.340 |
Why?
|
| Photochemotherapy | 1 | 2016 | 830 | 0.330 |
Why?
|
| Venous Thrombosis | 1 | 2019 | 1321 | 0.330 |
Why?
|
| Ethambutol | 1 | 2008 | 59 | 0.310 |
Why?
|
| Waldenstrom Macroglobulinemia | 3 | 2016 | 1077 | 0.310 |
Why?
|
| Uterine Neoplasms | 1 | 2017 | 1424 | 0.310 |
Why?
|
| Hemianopsia | 1 | 2010 | 121 | 0.310 |
Why?
|
| Rhinitis, Allergic, Perennial | 1 | 2008 | 60 | 0.310 |
Why?
|
| Neuromuscular Agents | 1 | 2010 | 148 | 0.310 |
Why?
|
| Vaccines, Inactivated | 1 | 2009 | 186 | 0.300 |
Why?
|
| Magnetic Resonance Imaging | 17 | 2020 | 36854 | 0.290 |
Why?
|
| Intracranial Pressure | 2 | 2021 | 325 | 0.290 |
Why?
|
| Immunosuppressive Agents | 4 | 2020 | 4207 | 0.290 |
Why?
|
| Parkinson Disease | 1 | 2021 | 2895 | 0.280 |
Why?
|
| Cataract | 1 | 2013 | 837 | 0.280 |
Why?
|
| Immunoglobulin G | 2 | 2018 | 4568 | 0.280 |
Why?
|
| Papilledema | 3 | 2018 | 130 | 0.280 |
Why?
|
| Eye Infections, Bacterial | 1 | 2010 | 239 | 0.270 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2010 | 238 | 0.270 |
Why?
|
| Arthralgia | 2 | 2011 | 459 | 0.270 |
Why?
|
| Solitary Nucleus | 2 | 1996 | 54 | 0.260 |
Why?
|
| Diagnostic Imaging | 2 | 2018 | 3538 | 0.250 |
Why?
|
| Cost-Benefit Analysis | 1 | 2018 | 5544 | 0.250 |
Why?
|
| Middle Aged | 29 | 2024 | 223737 | 0.250 |
Why?
|
| Circadian Rhythm | 1 | 2016 | 2593 | 0.240 |
Why?
|
| Leukocytosis | 3 | 2018 | 251 | 0.240 |
Why?
|
| Retinal Degeneration | 1 | 2008 | 414 | 0.230 |
Why?
|
| Aquaporin 4 | 2 | 2019 | 161 | 0.220 |
Why?
|
| Male | 41 | 2024 | 365203 | 0.220 |
Why?
|
| Brain | 6 | 2021 | 27453 | 0.220 |
Why?
|
| Blood Patch, Epidural | 1 | 2003 | 57 | 0.220 |
Why?
|
| Autoantibodies | 3 | 2019 | 2120 | 0.210 |
Why?
|
| Brain Diseases | 1 | 2012 | 1558 | 0.210 |
Why?
|
| Hemorrhage | 1 | 2015 | 3466 | 0.210 |
Why?
|
| Antibodies, Monoclonal | 2 | 2019 | 9264 | 0.210 |
Why?
|
| Antiviral Agents | 1 | 2015 | 3070 | 0.210 |
Why?
|
| Acetazolamide | 2 | 2018 | 98 | 0.210 |
Why?
|
| Glucagon-Like Peptides | 1 | 2024 | 157 | 0.210 |
Why?
|
| Disease Models, Animal | 3 | 2017 | 18354 | 0.200 |
Why?
|
| Hearing Loss | 1 | 2010 | 785 | 0.200 |
Why?
|
| Stroke | 2 | 2020 | 9756 | 0.200 |
Why?
|
| Diagnosis, Differential | 7 | 2019 | 13021 | 0.190 |
Why?
|
| Influenza Vaccines | 1 | 2009 | 781 | 0.190 |
Why?
|
| Meningeal Neoplasms | 1 | 2010 | 1258 | 0.180 |
Why?
|
| Recurrence | 5 | 2020 | 8513 | 0.180 |
Why?
|
| Electroretinography | 2 | 2016 | 524 | 0.180 |
Why?
|
| Retinal Hemorrhage | 1 | 2021 | 98 | 0.180 |
Why?
|
| Sex Reassignment Procedures | 1 | 2021 | 72 | 0.180 |
Why?
|
| Myelin Sheath | 2 | 2022 | 653 | 0.180 |
Why?
|
| Spinal Puncture | 2 | 2018 | 286 | 0.180 |
Why?
|
| Antitubercular Agents | 1 | 2008 | 1397 | 0.170 |
Why?
|
| Alzheimer Disease | 1 | 2021 | 8760 | 0.170 |
Why?
|
| Mutation | 6 | 2021 | 30266 | 0.160 |
Why?
|
| Skull Base Neoplasms | 2 | 2015 | 281 | 0.160 |
Why?
|
| Eye Pain | 1 | 2019 | 46 | 0.160 |
Why?
|
| Visual Pathways | 2 | 2016 | 559 | 0.160 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 4 | 2020 | 2831 | 0.160 |
Why?
|
| Glaucoma | 1 | 2008 | 1194 | 0.160 |
Why?
|
| Immunomodulation | 2 | 2020 | 549 | 0.160 |
Why?
|
| Neovascularization, Pathologic | 1 | 2009 | 2634 | 0.160 |
Why?
|
| Female | 28 | 2024 | 397515 | 0.160 |
Why?
|
| Brain Infarction | 2 | 2012 | 288 | 0.160 |
Why?
|
| Orbital Diseases | 1 | 2020 | 178 | 0.150 |
Why?
|
| Oligodendroglia | 1 | 2022 | 540 | 0.150 |
Why?
|
| Multiple Sclerosis | 4 | 2020 | 3250 | 0.150 |
Why?
|
| Carbonic Anhydrase Inhibitors | 1 | 2018 | 92 | 0.150 |
Why?
|
| Amygdala | 2 | 1996 | 1379 | 0.150 |
Why?
|
| Ciliary Arteries | 1 | 2017 | 19 | 0.150 |
Why?
|
| Orbital Implants | 1 | 2017 | 21 | 0.140 |
Why?
|
| Influenza, Human | 1 | 2009 | 1542 | 0.140 |
Why?
|
| Capillaries | 2 | 2017 | 756 | 0.140 |
Why?
|
| Coloboma | 1 | 2017 | 60 | 0.140 |
Why?
|
| Basal Ganglia Diseases | 1 | 2017 | 145 | 0.140 |
Why?
|
| Nerve Fibers | 2 | 2017 | 709 | 0.140 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2021 | 708 | 0.140 |
Why?
|
| Biopsy | 2 | 2020 | 6805 | 0.140 |
Why?
|
| Mycophenolic Acid | 1 | 2019 | 348 | 0.140 |
Why?
|
| Thailand | 1 | 2017 | 288 | 0.140 |
Why?
|
| Retinal Telangiectasis | 1 | 2016 | 26 | 0.130 |
Why?
|
| Synapses | 2 | 1996 | 1764 | 0.130 |
Why?
|
| Rats, Inbred BN | 1 | 2016 | 231 | 0.130 |
Why?
|
| Vision, Monocular | 1 | 2016 | 71 | 0.130 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 6401 | 0.130 |
Why?
|
| Orbit | 2 | 2017 | 459 | 0.130 |
Why?
|
| Myasthenia Gravis | 1 | 2018 | 217 | 0.130 |
Why?
|
| Efferent Pathways | 1 | 1996 | 165 | 0.130 |
Why?
|
| Aged | 16 | 2024 | 171786 | 0.130 |
Why?
|
| Photophobia | 1 | 2016 | 77 | 0.130 |
Why?
|
| Nerve Compression Syndromes | 1 | 2017 | 160 | 0.130 |
Why?
|
| Adult | 22 | 2021 | 223851 | 0.130 |
Why?
|
| Cerebrospinal Fluid | 1 | 2018 | 545 | 0.120 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2014 | 5434 | 0.120 |
Why?
|
| Steroids | 1 | 2020 | 938 | 0.120 |
Why?
|
| Postoperative Complications | 1 | 2017 | 15889 | 0.120 |
Why?
|
| Vision, Ocular | 1 | 2018 | 458 | 0.120 |
Why?
|
| Retinal Cone Photoreceptor Cells | 1 | 2016 | 183 | 0.120 |
Why?
|
| Optic Chiasm | 1 | 2014 | 91 | 0.120 |
Why?
|
| Blood Sedimentation | 1 | 2015 | 236 | 0.120 |
Why?
|
| Headache | 2 | 2018 | 1264 | 0.110 |
Why?
|
| Postoperative Period | 1 | 2019 | 1830 | 0.110 |
Why?
|
| Dystonia | 1 | 2017 | 378 | 0.110 |
Why?
|
| Intracranial Aneurysm | 1 | 2004 | 1293 | 0.110 |
Why?
|
| Endoscopy | 2 | 2017 | 1862 | 0.110 |
Why?
|
| Hormone Replacement Therapy | 1 | 2019 | 757 | 0.110 |
Why?
|
| Angiography | 1 | 2018 | 1598 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2013 | 310 | 0.100 |
Why?
|
| Decompression, Surgical | 1 | 2017 | 610 | 0.100 |
Why?
|
| Anesthesia, Local | 1 | 2014 | 279 | 0.100 |
Why?
|
| Membrane Transport Proteins | 1 | 2017 | 1038 | 0.100 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2016 | 8144 | 0.100 |
Why?
|
| Hypoglycemic Agents | 1 | 2024 | 3110 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2012 | 20776 | 0.090 |
Why?
|
| Panuveitis | 1 | 2011 | 33 | 0.090 |
Why?
|
| General Practitioners | 1 | 2012 | 103 | 0.090 |
Why?
|
| Managed Care Programs | 1 | 2016 | 941 | 0.090 |
Why?
|
| Retrospective Studies | 11 | 2024 | 81903 | 0.090 |
Why?
|
| Lung Neoplasms | 2 | 2014 | 13594 | 0.090 |
Why?
|
| Fractures, Bone | 1 | 2023 | 2063 | 0.090 |
Why?
|
| Sweet Syndrome | 1 | 2011 | 56 | 0.090 |
Why?
|
| Erythrocyte Transfusion | 1 | 2016 | 575 | 0.090 |
Why?
|
| gamma-Aminobutyric Acid | 2 | 1996 | 1141 | 0.090 |
Why?
|
| Cauda Equina | 1 | 2010 | 45 | 0.090 |
Why?
|
| Electrophysiology | 1 | 2013 | 1266 | 0.090 |
Why?
|
| Tropheryma | 1 | 2010 | 4 | 0.090 |
Why?
|
| Early Diagnosis | 1 | 2015 | 1194 | 0.090 |
Why?
|
| Genetic Testing | 2 | 2017 | 3591 | 0.090 |
Why?
|
| Follow-Up Studies | 5 | 2019 | 39394 | 0.090 |
Why?
|
| Lymphocytes | 1 | 2018 | 2614 | 0.090 |
Why?
|
| Bone Marrow Transplantation | 1 | 2018 | 2709 | 0.090 |
Why?
|
| Carcinoma, Papillary | 1 | 2015 | 793 | 0.090 |
Why?
|
| Positron-Emission Tomography | 2 | 2017 | 6673 | 0.090 |
Why?
|
| Adrenal Cortex Hormones | 3 | 2011 | 1892 | 0.080 |
Why?
|
| Thalamus | 1 | 2016 | 1049 | 0.080 |
Why?
|
| Sphenoid Bone | 1 | 2010 | 177 | 0.080 |
Why?
|
| Prognosis | 4 | 2020 | 30046 | 0.080 |
Why?
|
| Neuroprotective Agents | 1 | 2016 | 958 | 0.080 |
Why?
|
| Injections, Intramuscular | 1 | 2010 | 556 | 0.080 |
Why?
|
| Neural Pathways | 3 | 1996 | 3120 | 0.080 |
Why?
|
| Rats | 6 | 2016 | 23786 | 0.080 |
Why?
|
| Immunocompetence | 1 | 2008 | 138 | 0.080 |
Why?
|
| Mycobacterium avium-intracellulare Infection | 1 | 2008 | 82 | 0.080 |
Why?
|
| Enophthalmos | 1 | 2008 | 34 | 0.080 |
Why?
|
| Myelitis, Transverse | 1 | 2008 | 40 | 0.080 |
Why?
|
| Testosterone | 1 | 2019 | 2493 | 0.080 |
Why?
|
| Genetic Linkage | 1 | 2013 | 2342 | 0.070 |
Why?
|
| Neurons | 3 | 2016 | 9519 | 0.070 |
Why?
|
| Genes, Neurofibromatosis 1 | 1 | 2008 | 74 | 0.070 |
Why?
|
| Genome, Mitochondrial | 1 | 2008 | 68 | 0.070 |
Why?
|
| Aged, 80 and over | 8 | 2017 | 59739 | 0.070 |
Why?
|
| Anesthetics, Local | 1 | 2014 | 1005 | 0.070 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2014 | 1434 | 0.070 |
Why?
|
| Paranasal Sinus Diseases | 1 | 2008 | 121 | 0.070 |
Why?
|
| Orbital Fractures | 1 | 2008 | 109 | 0.070 |
Why?
|
| Photoreceptor Cells, Vertebrate | 1 | 2008 | 203 | 0.070 |
Why?
|
| Neoplasm Metastasis | 1 | 2017 | 4926 | 0.070 |
Why?
|
| Maxillary Sinus | 1 | 2008 | 175 | 0.070 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2015 | 2056 | 0.070 |
Why?
|
| Young Adult | 6 | 2021 | 60131 | 0.070 |
Why?
|
| Neurofibromin 1 | 1 | 2008 | 190 | 0.070 |
Why?
|
| Paranasal Sinuses | 1 | 2008 | 267 | 0.070 |
Why?
|
| Viral Load | 1 | 2015 | 3398 | 0.060 |
Why?
|
| Craniotomy | 1 | 2010 | 747 | 0.060 |
Why?
|
| Risk Factors | 5 | 2024 | 74976 | 0.060 |
Why?
|
| Mycoses | 1 | 2008 | 386 | 0.060 |
Why?
|
| Radiopharmaceuticals | 1 | 2015 | 2734 | 0.060 |
Why?
|
| Graft vs Host Disease | 1 | 2018 | 3048 | 0.060 |
Why?
|
| Health Care Costs | 1 | 2018 | 3270 | 0.060 |
Why?
|
| Behcet Syndrome | 1 | 2006 | 86 | 0.060 |
Why?
|
| Hepatitis C | 1 | 2015 | 1595 | 0.060 |
Why?
|
| Maxilla | 1 | 2008 | 489 | 0.060 |
Why?
|
| Electromyography | 1 | 2010 | 1401 | 0.060 |
Why?
|
| Seizures | 1 | 2017 | 3000 | 0.060 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2017 | 3411 | 0.060 |
Why?
|
| Immunotherapy | 1 | 2020 | 4756 | 0.060 |
Why?
|
| Microscopy, Electron | 3 | 1996 | 2560 | 0.060 |
Why?
|
| Life Tables | 1 | 2004 | 368 | 0.060 |
Why?
|
| Cohort Studies | 2 | 2017 | 41808 | 0.060 |
Why?
|
| Carcinoma | 1 | 2015 | 2340 | 0.060 |
Why?
|
| Animals | 8 | 2017 | 169335 | 0.060 |
Why?
|
| Treatment Outcome | 4 | 2019 | 65480 | 0.060 |
Why?
|
| C-Reactive Protein | 1 | 2015 | 3859 | 0.050 |
Why?
|
| Migraine Disorders | 1 | 2016 | 1713 | 0.050 |
Why?
|
| Culture | 1 | 2007 | 623 | 0.050 |
Why?
|
| Nasal Polyps | 1 | 2008 | 412 | 0.050 |
Why?
|
| Head | 1 | 2009 | 927 | 0.050 |
Why?
|
| Presynaptic Terminals | 2 | 1995 | 302 | 0.050 |
Why?
|
| Pattern Recognition, Visual | 1 | 2008 | 826 | 0.050 |
Why?
|
| Intracranial Embolism | 1 | 2004 | 189 | 0.050 |
Why?
|
| Adolescent | 5 | 2021 | 89244 | 0.050 |
Why?
|
| Limbic System | 2 | 1994 | 424 | 0.050 |
Why?
|
| Thyroid Neoplasms | 1 | 2015 | 2360 | 0.050 |
Why?
|
| Injections, Epidural | 1 | 2003 | 203 | 0.050 |
Why?
|
| Neurosurgical Procedures | 2 | 2010 | 2110 | 0.050 |
Why?
|
| New York City | 1 | 2004 | 737 | 0.050 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 12562 | 0.050 |
Why?
|
| Thrombophilia | 1 | 2004 | 308 | 0.050 |
Why?
|
| Systemic Vasculitis | 1 | 2020 | 37 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2024 | 12253 | 0.040 |
Why?
|
| Apoptosis | 1 | 2016 | 9527 | 0.040 |
Why?
|
| Arteriosclerosis | 1 | 2004 | 1056 | 0.040 |
Why?
|
| Retinal Diseases | 1 | 2006 | 710 | 0.040 |
Why?
|
| Sinusitis | 1 | 2008 | 998 | 0.040 |
Why?
|
| Phosphorus Radioisotopes | 1 | 2018 | 100 | 0.040 |
Why?
|
| Lymph Nodes | 1 | 2010 | 3473 | 0.040 |
Why?
|
| Immunohistochemistry | 4 | 1996 | 11116 | 0.040 |
Why?
|
| United States | 2 | 2017 | 73186 | 0.040 |
Why?
|
| Aneurysm, Ruptured | 1 | 2004 | 462 | 0.040 |
Why?
|
| Recovery of Function | 1 | 2008 | 2990 | 0.040 |
Why?
|
| Carbidopa | 1 | 2017 | 30 | 0.040 |
Why?
|
| Immunization, Passive | 1 | 2020 | 619 | 0.040 |
Why?
|
| Catecholamines | 2 | 1995 | 389 | 0.040 |
Why?
|
| Demyelinating Diseases | 1 | 2020 | 358 | 0.040 |
Why?
|
| Tegmentum Mesencephali | 2 | 1994 | 59 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2004 | 1794 | 0.040 |
Why?
|
| Levodopa | 1 | 2017 | 221 | 0.030 |
Why?
|
| Face | 1 | 2023 | 1031 | 0.030 |
Why?
|
| Biotin | 1 | 2017 | 256 | 0.030 |
Why?
|
| Thiamine | 1 | 2017 | 160 | 0.030 |
Why?
|
| Phytohemagglutinins | 1 | 1995 | 165 | 0.030 |
Why?
|
| Dilatation, Pathologic | 1 | 2017 | 527 | 0.030 |
Why?
|
| Dendrites | 2 | 1995 | 472 | 0.030 |
Why?
|
| Incidence | 2 | 2024 | 21547 | 0.030 |
Why?
|
| Neurons, Efferent | 1 | 1995 | 81 | 0.030 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2017 | 292 | 0.030 |
Why?
|
| Neoplasms | 1 | 2004 | 22389 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2012 | 7460 | 0.030 |
Why?
|
| Microinjections | 1 | 1995 | 322 | 0.030 |
Why?
|
| Stilbamidines | 1 | 1994 | 43 | 0.030 |
Why?
|
| Macrophages | 1 | 2010 | 5801 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2016 | 11886 | 0.030 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 1995 | 368 | 0.030 |
Why?
|
| Afferent Pathways | 1 | 1995 | 304 | 0.030 |
Why?
|
| Europe | 1 | 2021 | 3441 | 0.030 |
Why?
|
| Embolization, Therapeutic | 1 | 2004 | 1410 | 0.030 |
Why?
|
| Vincristine | 1 | 2016 | 1040 | 0.030 |
Why?
|
| Microvessels | 1 | 2017 | 586 | 0.030 |
Why?
|
| Paraproteinemias | 1 | 2016 | 252 | 0.030 |
Why?
|
| Age of Onset | 1 | 2020 | 3346 | 0.030 |
Why?
|
| Serotonin | 2 | 1994 | 1043 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2020 | 42683 | 0.020 |
Why?
|
| Neural Inhibition | 1 | 1995 | 588 | 0.020 |
Why?
|
| Fourier Analysis | 1 | 2012 | 441 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2004 | 10115 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2017 | 2089 | 0.020 |
Why?
|
| Retinal Detachment | 1 | 2016 | 429 | 0.020 |
Why?
|
| Age Factors | 1 | 2008 | 18435 | 0.020 |
Why?
|
| Meningitis, Aseptic | 1 | 2011 | 59 | 0.020 |
Why?
|
| Brachytherapy | 1 | 2018 | 1224 | 0.020 |
Why?
|
| Disease Progression | 1 | 2008 | 13674 | 0.020 |
Why?
|
| Neurotransmitter Agents | 1 | 1994 | 663 | 0.020 |
Why?
|
| Antirheumatic Agents | 1 | 2020 | 1381 | 0.020 |
Why?
|
| Prevalence | 1 | 2007 | 15879 | 0.020 |
Why?
|
| Cyclophosphamide | 1 | 2016 | 2227 | 0.020 |
Why?
|
| Photic Stimulation | 1 | 2016 | 2003 | 0.020 |
Why?
|
| Comorbidity | 1 | 2004 | 10592 | 0.020 |
Why?
|
| Embolism | 1 | 2012 | 401 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2017 | 4124 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2022 | 3836 | 0.020 |
Why?
|
| Radioisotopes | 1 | 2010 | 517 | 0.020 |
Why?
|
| Ophthalmic Artery | 1 | 2009 | 58 | 0.020 |
Why?
|
| Methylprednisolone Hemisuccinate | 1 | 2008 | 8 | 0.020 |
Why?
|
| Thrombocytosis | 1 | 2009 | 88 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2017 | 2055 | 0.020 |
Why?
|
| Nasal Bone | 1 | 2008 | 58 | 0.020 |
Why?
|
| Hypertension | 2 | 2009 | 8617 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2017 | 2592 | 0.020 |
Why?
|
| Methotrexate | 1 | 2014 | 1723 | 0.020 |
Why?
|
| Smoking | 1 | 2004 | 9094 | 0.020 |
Why?
|
| Dexamethasone | 1 | 2014 | 1965 | 0.020 |
Why?
|
| Dopamine | 1 | 1994 | 1596 | 0.020 |
Why?
|
| Smoking Cessation | 1 | 2018 | 2085 | 0.020 |
Why?
|
| Cyclopentolate | 1 | 2006 | 6 | 0.020 |
Why?
|
| Exanthema | 1 | 2011 | 503 | 0.020 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2014 | 1535 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2008 | 18068 | 0.020 |
Why?
|
| Diabetic Retinopathy | 1 | 2016 | 1299 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 4785 | 0.020 |
Why?
|
| Anemia | 1 | 2016 | 1517 | 0.020 |
Why?
|
| Mydriatics | 1 | 2006 | 67 | 0.020 |
Why?
|
| Genital Diseases, Male | 1 | 2006 | 84 | 0.020 |
Why?
|
| Oral Ulcer | 1 | 2006 | 96 | 0.020 |
Why?
|
| Gadolinium | 1 | 2010 | 965 | 0.020 |
Why?
|
| Prednisolone | 1 | 2006 | 327 | 0.020 |
Why?
|
| Ulcer | 1 | 2006 | 203 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 8559 | 0.010 |
Why?
|
| Fever | 1 | 2011 | 1619 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2008 | 2231 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 2004 | 9213 | 0.010 |
Why?
|
| Proteins | 1 | 2017 | 6011 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2009 | 2664 | 0.010 |
Why?
|
| Functional Laterality | 1 | 2009 | 2267 | 0.010 |
Why?
|
| Immunologic Factors | 1 | 2011 | 1597 | 0.010 |
Why?
|
| Syndrome | 1 | 2008 | 3274 | 0.010 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2011 | 1811 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2004 | 11230 | 0.010 |
Why?
|
| Radiography | 1 | 2012 | 6991 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 2 | 1994 | 1705 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2017 | 7885 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2011 | 4356 | 0.010 |
Why?
|
| Cerebrovascular Circulation | 1 | 2009 | 2734 | 0.010 |
Why?
|
| Neutrophils | 1 | 2011 | 3785 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2006 | 6320 | 0.010 |
Why?
|
| Wounds and Injuries | 1 | 2008 | 2517 | 0.010 |
Why?
|
| Gold Colloid | 1 | 1994 | 12 | 0.010 |
Why?
|
| Silver Staining | 1 | 1994 | 63 | 0.010 |
Why?
|
| Wheat Germ Agglutinins | 1 | 1994 | 47 | 0.010 |
Why?
|
| Wheat Germ Agglutinin-Horseradish Peroxidase Conjugate | 1 | 1994 | 36 | 0.010 |
Why?
|
| Horseradish Peroxidase | 1 | 1994 | 170 | 0.010 |
Why?
|
| Fluorescence | 1 | 1994 | 757 | 0.010 |
Why?
|
| Child | 1 | 2020 | 80960 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 1994 | 1933 | 0.000 |
Why?
|
| Time Factors | 1 | 2008 | 40261 | 0.000 |
Why?
|